Skip to main content
FinSpry Logo
FinSpry
WST logo
WST
(NYSE)
West Pharmaceutical Services, Inc.
$305.50-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

West Pharmaceutical Services (WST) Stock Price & Financial Analysis

West Pharmaceutical Services Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$299.72 - $305.76
52-Week High$330.88
52-Week Low$202.79
Open$303.99
Volume634.08K
Average Volume (3M)926.36K
Market Cap22.00B
Shares Outstanding72.40M
P/E Ratio (TTM)40.39
Forward P/E35.26
Price to Sales (P/S)6.83
Price to Book (P/B)7.36
EV/EBITDA27.39
Revenue (TTM)3.22B
Net Income (TTM)544.80M
Free Cash Flow (TTM)458.00M
EPS (TTM)$7.50
Profit Margin16.92%
Operating Margin20.48%
Return on Equity (ROE)18.22%
Debt to Equity0.07
50-Day MA$267.46
200-Day MA$262.13
52-Week Change46.86%
Annual Dividend$0.87
Dividend Yield0.28%
Payout Ratio11.60%
Last Dividend Ex-DateApr 29, 2026

Frequently Asked Questions About West Pharmaceutical Services

What is the current stock price for WST?

As of the latest trading session, WST stock trades at $305.50. The 52-week range is $202.79–$330.88, with a day range of $299.72–$305.76.

What is the P/E ratio for WST?

West Pharmaceutical Services's trailing P/E ratio is 40.4, meaning investors pay $40.4 for every $1 of annual earnings. The forward P/E is 35.3, reflecting analyst expectations for future earnings. West Pharmaceutical Services operates in the Healthcare sector.

Does WST pay dividends?

Yes, West Pharmaceutical Services pays a 0.28% annual dividend yield ($0.87 per share). The payout ratio is 11.6%. The last ex-dividend date was 2026-04-29.

What do analysts recommend for WST?

Based on 1 analyst, the consensus for WST is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of WST?

West Pharmaceutical Services's market capitalization is $22.12B, classifying it as a large-cap company. West Pharmaceutical Services operates in the Healthcare sector within the Medical Instruments & Supplies industry.